BEIJING, January 19 (TMTPOST) — Pakistan's authority said on Monday that it has approved Sinopharm's COVID-19 vaccines for emergency use in the southern Asian country.
Pakistan has so far approved two COVID-19 vaccines, one developed by Chinese state-owned pharmaceutical company Sinopharm and the other co-developed by AstraZeneca and Oxford University. Both vaccines have passed safety and efficacy evaluation.